Similar articles for PMID: 17660345

Year	Number of Results
1993	1
1994	3
1996	2
1998	1
1999	1
2000	2
2001	3
2002	4
2003	1
2004	3
2005	2
2006	2
2007	2
2008	3
2009	1
2024	0

1

CD10 positivity in breast epithelial neoplasms.

Bains AS, Sidhu JS. Bains AS, et al. J Clin Pathol. 2007 Aug;60(8):958-9. doi: 10.1136/jcp.2007.047191. J Clin Pathol. 2007. PMID: 17660345 Free PMC article. No abstract available.

2

Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.

Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T. Moritani S, et al. Mod Pathol. 2002 Apr;15(4):397-405. doi: 10.1038/modpathol.3880536. Mod Pathol. 2002. PMID: 11950913

3

Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: a preliminary study of 30 cases.

Li JH, Man YG. Li JH, et al. Cancer Biomark. 2009;5(3):109-16. doi: 10.3233/CBM-2009-0595. Cancer Biomark. 2009. PMID: 19407365

4

Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.

Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K. Iwaya K, et al. Virchows Arch. 2002 Jun;440(6):589-93. doi: 10.1007/s00428-002-0639-4. Epub 2002 Apr 13. Virchows Arch. 2002. PMID: 12070597

5

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.

Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P. Lefebvre S, et al. J Pathol. 2002 Mar;196(3):266-74. doi: 10.1002/path.1039. J Pathol. 2002. PMID: 11857488

6

Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.

de Moraes Schenka NG, Schenka AA, de Souza Queiroz L, de Almeida Matsura M, Vassallo J, Alvarenga M. de Moraes Schenka NG, et al. Breast J. 2008 Jan-Feb;14(1):68-75. doi: 10.1111/j.1524-4741.2007.00518.x. Epub 2007 Dec 11. Breast J. 2008. PMID: 18086274

7

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast.

Regele S, Kohlberger P, Vogl FD, Böhm W, Kreienberg R, Runnebaum IB. Regele S, et al. Br J Cancer. 1999 Oct;81(4):702-4. doi: 10.1038/sj.bjc.6690751. Br J Cancer. 1999. PMID: 10574259 Free PMC article.

8

Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.

Sapino A, Bongiovanni M, Cassoni P, Righi L, Arisio R, Deaglio S, Malavasi F. Sapino A, et al. J Pathol. 2001 Jun;194(2):254-61. doi: 10.1002/1096-9896(200106)194:2<254::AID-PATH880>3.0.CO;2-2. J Pathol. 2001. PMID: 11400156

9

Experience with CA 15.3 as a tumor marker in breast cancer.

Barros AC, Fry W Jr, Nazario AC, Santos MO, Sato MK. Barros AC, et al. Eur J Surg Oncol. 1994 Apr;20(2):130-3. Eur J Surg Oncol. 1994. PMID: 8181577

10

Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.

Dell'Erba L, Calo-Gabrieli G, Caruso ML, Thomas R, Cortino G, Valentini AM, Muto P, Albrizio M, Pastena MI, Lastoria S. Dell'Erba L, et al. Anticancer Res. 2001 Mar-Apr;21(2A):925-30. Anticancer Res. 2001. PMID: 11396186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year